Skeletal muscle area correlates with body surface area in healthy adults

Hepatology Research

Volumn 44, Issue 3, 2014, Pages 313-318

  Yoshizumi, Tomoharu ^a   Shirabe, Ken ^a   Nakagawara, Hidekazu ^a   Ikegami, Toru ^a   Harimoto, Norifumi ^a   Toshima, Takeo ^a   Yamashita, Yo ichi ^a   Ikeda, Tetsuo ^a   Soejima, Yuji ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Body surface area; Computed tomography; Sarcopenia; Skeletal muscle area

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY SURFACE; BODY WEIGHT; CALCULATION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; JAPANESE; LIVER TRANSPLANTATION; LUMBAR VERTEBRA; MALE; MIDDLE AGED; NORMAL HUMAN; ORGAN DONOR; PRIORITY JOURNAL; PSOAS MUSCLE; SARCOPENIA; SEX DIFFERENCE; SKELETAL MUSCLE; SKELETAL MUSCLE AREA; YOUNG ADULT;

EID: 84895195610     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12119     Document Type: Article

References (18)

1. Fearon KC. Cancer cachexia and fat-muscle physiology. N Engl J Med 2011; 365: 565-567.
2. van Vledder MG, Levolger S, Ayez N, Verhoef C, Tran TC, Ijzermans JN. Body composition and outcome in patients undergoing resection of colorectal liver metastases. Br J Surg 2012; 99: 550-557.
3. Sabel MS, Lee J, Cai S, Englesbe MJ, Holcombe S, Wang S. Sarcopenia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol 2011; 18: 3579-3585.
4. Tan BH, Birdsell LA, Martin L, Baracos VE, Fearon KC. Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 2009; 15: 6973-6979.
5. Tandon P, Ney M, Irwin I etal. Severe muscle depletion in patients on the liver transplant wait list - its prevalence and independent prognostic value. Liver Transpl 2012; 18: 1209-1216.
6. Fearon K, Strasser F, Anker SD etal. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 2011; 12: 489-495.
7. Englesbe MJ, Patel SP, He K etal. Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010; 211: 271-278.
8. Mosteller RD. Simplified calculation of body-surface area. N Engl J Med 1987; 317: 1098.
9. NIH Technology Assessment Conference Panel. Methods for voluntary weight loss and control. Ann Intern Med 1992; 116: 942-949.
10. Yoshizumi T, Gondolesi GE, Bodian CA etal. A simple new formula to assess liver weight. Transplant Proc 2003; 35: 1415-1420.
11. Peng P, Hyder O, Firoozmand A etal. Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg 2012; 16: 1478-1486.
12. Englesbe MJ, Lee JS, He K etal. Analytic morphomics, core muscle size, and surgical outcomes. Ann Surg 2012; 256: 255-261.
13. Urata K, Kawasaki S, Matsunami H etal. Calculation of child and adult standard liver volume for liver transplantation. Hepatology 1995; 21: 1317-1321.
14. Yoshizumi T, Shirabe K, Ikegami T etal. Impact of human T cell leukemia virus type 1 in living donor liver transplantation. Am J Transplant 2012; 12: 1479-1485.
15. Mitchell WK, Williams J, Atherton P, Larvin M, Lund J, Narici M. Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review. Front Physiol 2012; 3: 260.
16. Lutz CT, Quinn LS. Sarcopenia, obesity, and natural killer cell immune senescence in aging: altered cytokine levels as a common mechanism. Aging (Albany NY) 2012; 4: 535-546.
17. Kitajima Y, Eguchi Y, Ishibashi E etal. Age-related fat deposition in multifidus muscle could be a marker for nonalcoholic fatty liver disease. J Gastroenterol 2010; 45: 218-224.
18. Taniguchi E, Kawaguchi T, Otsuka M, Uchida Y, Nagamatsu A, Itou M. Nutritional assessments for ordinary medical care in patients with chronic liver disease. Hepatol Res 2013; 43: 192-199.